154 related articles for article (PubMed ID: 6775857)
1. N tau-Methylhistidine excretion and myofibrillar protein breakdown in patients receiving intravenous or enteral nutrition.
Holbrook IB; Gross E; Milewski PJ; Shipley K; Irving MH
Clin Sci (Lond); 1980 Sep; 59(3):211-4. PubMed ID: 6775857
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent changes in the rate of myofibrillar protein degradation in humans as assessed by 3-methylhistidine and creatinine excretion.
Tomas FM; Ballard FJ; Pope LM
Clin Sci (Lond); 1979 Apr; 56(4):341-6. PubMed ID: 477219
[TBL] [Abstract][Full Text] [Related]
3. Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.
Ballard FJ; Tomas FM; Stern LM
Clin Sci (Lond); 1979 Apr; 56(4):347-52. PubMed ID: 477220
[TBL] [Abstract][Full Text] [Related]
4. Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting.
Zoli M; Marchesini G; Dondi C; Bianchi GP; Pisi E
Clin Sci (Lond); 1982 Jun; 62(6):683-6. PubMed ID: 7083759
[TBL] [Abstract][Full Text] [Related]
5. Myofibrillar protein turnover and urinary N-tau-methylhistidine output. Response to dietary supply of protein and energy.
Haverberg LN; Deckelbaum L; Bilmazes C; Munro HN; Young VR
Biochem J; 1975 Dec; 152(3):503-10. PubMed ID: 1227503
[TBL] [Abstract][Full Text] [Related]
6. Muscle protein degradation in premature human infants.
Ballard FJ; Tomas FM; Pope LM; Hendry PG; James BE; Macmahon RA
Clin Sci (Lond); 1979 Dec; 57(6):535-44. PubMed ID: 117967
[TBL] [Abstract][Full Text] [Related]
7. Myofibrillar protein degradation in premature infants with respiratory distress as assessed by 3-methylhistidine and creatinine excretions.
Lunyong VE; Friedman Z
Am J Clin Nutr; 1982 Sep; 36(3):485-91. PubMed ID: 7113954
[TBL] [Abstract][Full Text] [Related]
8. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
[TBL] [Abstract][Full Text] [Related]
9. Myofibrillar protein catabolism in rat steroid myopathy measured by 3-methylhistidine excretion in the urine.
Shoji S
J Neurol Sci; 1989 Nov; 93(2-3):333-40. PubMed ID: 2592991
[TBL] [Abstract][Full Text] [Related]
10. Endogenous 3-methylhistidine excretion in healthy women and men with reference to muscle protein metabolism.
Neuhäuser M; Bässler KH
Z Ernahrungswiss; 1984 Sep; 23(3):171-80. PubMed ID: 6506809
[TBL] [Abstract][Full Text] [Related]
11. Comparison of human myofibrillar protein catabolic rate derived from 3-methylhistidine excretion with synthetic rate from muscle biopsies during L-[alpha-15N]lysine infusion.
McKeran RO; Halliday D; Purkiss P
Clin Sci Mol Med; 1978 May; 54(5):471-5. PubMed ID: 750147
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone-induced changes in myofibrillar protein breakdown in hypopituitary children.
Ballard FJ; Burgoyne JL; Tomas FM; Penfold JL
Clin Sci (Lond); 1983 Mar; 64(3):315-20. PubMed ID: 6822063
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.
Elia M; Carter A; Bacon S; Winearls CG; Smith R
Br Med J (Clin Res Ed); 1981 Jan; 282(6261):351-4. PubMed ID: 6780020
[TBL] [Abstract][Full Text] [Related]
14. Quantitative importance of non-skeletal-muscle N tau-methylhistidine and creatine in human urine.
Afting EG; Bernhardt W; Janzen RW; Röthig HJ
Biochem J; 1981 Nov; 200(2):449-52. PubMed ID: 7340846
[TBL] [Abstract][Full Text] [Related]
15. Measurements of myofibrillar protein breakdown in newborn human infants.
Burgoyne JL; Ballard FJ; Tomas FM; Dobozy A; MacLennan AH; Fitzgerald A; Dahlenburg GW
Clin Sci (Lond); 1982 Nov; 63(5):421-7. PubMed ID: 7116782
[TBL] [Abstract][Full Text] [Related]
16. Myofibrillar protein degradation in the chicken. 3-Methylhistidine release in vivo and in vitro in normal and genetically muscular-dystrophic chickens.
Hillgartner FB; Williams AS; Flanders JA; Morin D; Hansen RJ
Biochem J; 1981 May; 196(2):591-601. PubMed ID: 7316997
[TBL] [Abstract][Full Text] [Related]
17. Sequential urinary N tau-methylhistidine to creatinine ratios in premature infants.
Burgoyne JL; Fitzgerald A; Dahlenburg GW; Haslam RR; Tomas FM; Ballard FJ
Muscle Nerve; 1986 Jan; 9(1):24-9. PubMed ID: 3951478
[TBL] [Abstract][Full Text] [Related]
18. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
McKeran RO; Halliday D; Purkiss P
J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
[TBL] [Abstract][Full Text] [Related]
19. Interactive effects of insulin and corticosterone on myofibrillar protein turnover in rats as determined by N tau-methylhistidine excretion.
Tomas FM; Murray AJ; Jones LM
Biochem J; 1984 Jun; 220(2):469-79. PubMed ID: 6378188
[TBL] [Abstract][Full Text] [Related]
20. N tau-methylhistidine content of organs and tissues of cattle and an attempt to estimate fractional catabolic and synthetic rates of myofibrillar proteins of skeletal muscle during growth by measuring urinary output of N tau-methylhistidine.
Nishizawa N; Toyoda Y; Noguchi T; Hareyama S; Itabashi H; Funabiki R
Br J Nutr; 1979 Sep; 42(2):247-52. PubMed ID: 476040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
